“Where can I do a Pap smear test?” is a question that frequently appears in social media discussions around cervical cancer awareness in Nigeria, and it is not asked out of ignorance. It is asked because access is not straightforward. Women are willing and aware that early screening would go a long way, but willingness does not automatically translate to access.
Across Nigeria, cervical cancer screening rates remain critically low. While there is no single nationwide figure, a review of multiple studies shows that uptake typically ranges between 0.6% and 10%. A 2025 study published in the Nigerian Medical Journal found that only 6.5% of women surveyed in Ogun State had ever undergone screening
The consequences are visible in how the disease is detected. Most women who are eventually diagnosed do not find out early, and by the time they present at hospitals, the cancer is most often already at an advanced stage.
This is not simply a matter of awareness. Many of these women already knew about screening and were willing to take the test. But with uptake still low, late detection remains the pattern.
Advanced-stage diagnosis reduces survival chances, limits treatment options, and worsens outcomes, which is why cervical cancer remains one of the leading causes of cancer-related deaths among Nigerian women
See also: Pain Is Not a Portion: The Menstrual Health Conversations Nigerian Women Are Still Not Having
In theory, cervical cancer screening exists in Nigeria. Pap smears and HPV tests are available in some tertiary hospitals, selected private clinics, and a few primary healthcare centers. In practice, however, access is uneven, inconsistent, and most of the time unclear to the very women it is meant for.
For many women, the first challenge is simply not knowing where to go. Screening is not uniformly advertised or integrated into routine healthcare visits, which means women often only encounter it during specific campaigns or when they actively search for it.
Even when facilities exist, access is shaped by geography. Urban centers are more likely to have screening services, while rural communities often depend on outreach programs or must travel long distances to access care.
In some facilities, screening is not consistently available due to equipment limitations, staffing shortages, or irregular service schedules, meaning a woman may arrive ready to be screened and still be turned away or asked to return another day.
Cost further complicates access. While some public facilities offer subsidized or free screening during campaigns, fees still apply in many private settings, placing it out of reach for a significant number of women.
Access, then, is not just about the availability of a test. It is shaped by information gaps and an uneven distribution of services, creating a system where prevention is technically available but not reliably so. In public health, unpredictability is a barrier.
One woman who shared her experience on TikTok described going to a general hospital for a cervical cancer screening, only to be redirected without clear direction. “At first, they kept sending me from one place to another,” she said. “At the end, I was told the doctors were on strike.”
Even where services were theoretically available, the system itself became the obstacle.
Another woman put it plainly: “The process is disheartening, largely because of how expensive the tests can be.”
Both experiences point to the same pattern. The issue is not always a lack of awareness or willingness, but what happens when women act on that willingness and encounter a system that is inconsistent, costly, or simply unavailable.
Faith Edobor, a gynecologist practicing in Nigeria, noted in an interview that many cervical cancer patients still present at advanced stages of the disease, often in their fifties and above, which reflects delayed detection. She observed that while awareness and willingness to get screened have increased, actual screening rates remain low. When asked what the primary barrier to women getting screened was, her answer was direct: financial constraints.
She also described the broader healthcare system as insufficiently equipped to handle cervical cancer screening at any meaningful scale.
Her assessment reinforces the recurring reality that the question is not simply whether women are willing to be screened, but whether the system can support that willingness when it exists.
See also: To Have Children or Not: Dilemma Of Today’s Women
These Gaps Must be Addressed?
Addressing this takes more than awareness campaigns. Access to screening needs to be built into the structure of the healthcare system itself. That means expanding services beyond major general or private hospitals and integrating them into primary healthcare, where more women are likely to seek routine care.
Cost has been identified as a significant barrier, which points to the need for consistent subsidies or free screening programs, not just during periodic campaigns, but as a standard and reliable offering. Consistency matters too. Screening services must be reliably available, with adequate staffing and equipment, so that women who present at facilities are not turned away or asked to return repeatedly.
The truth is that Nigerian women want to get screened but there isn’t enough access. The question is not about women being ready. It is about whether the system can meet them at the point of that readiness and consistently hold them there.
Because right now, it does not.
